$CL

Colgate-Palmolive Non-GAAP EPS of $0.97 beats by $0.04, revenue of $5.37B beats by $40M (CL:NYSE)

Colgate-Palmolive reported Q3 Non-GAAP EPS of $0.97, exceeding estimates by $0.04, with revenue of $5.37B, up 4.7% Y/Y and $40M above expectations. Net sales rose 4.6%, while organic sales increased 3.6%, impacted by lower private label pet food sales.

Original reporting
Published Oct 30, 2026, 10:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:06 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CL
Bullish
high confidence
Mentioned
$CL
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CLBullishHigh
01

Why it matters

The beat may trigger buying interest from income‑focused investors and could influence sector sentiment.

02

Market read

Earnings beat is a primary catalyst for the stock and may affect related consumer‑staples equities.

03

What to watch

Potential margin pressure from higher input costs not disclosed in the brief.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Colgate‑Palmolive’s Q3 earnings release provides the first public disclosure of the latest financial results.

Company-level read

Ticker impact

$CLBullishHigh confidence
Context

Colgate-Palmolive reported Q3 Non‑GAAP EPS of $0.97, beating expectations by $0.04 and revenue of $5.37B, up 4.7% YoY, beating by $40M.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded consensus, and the beat size is material for a mid‑cap consumer staples company.

Market effects

May lift other consumer‑staples peers as the sector shows resilience.

Positive for U.S. consumer‑goods stocks in early trading.

Limited to U.S. markets; no direct global effect.

Counterpoint

If the beat is already priced in, the stock could face a short‑term pullback.

Key entities

  • Colgate‑Palmolive

    Consumer‑staples manufacturer reporting Q3 results.

Related articles

$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

$CLHighAI 8/10

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.